Contributors

Michael T. Brady, MD, is associate medical director at Nationwide Children’s Hospital, co-medical director for Patient Safety, a member of the hospital’s Division of Infectious Diseases and a Professor of Pediatrics at The Ohio State University College of Medicine. An infectious disease specialist for more than three decades, Dr. Brady began focusing on the emerging HIV epidemic in the mid-1980s and its implications for infants, children and adolescents. He created the country’s first family-centered pediatric HIV program at Nationwide Children’s in 1987. While still involved with the HIV program, his interests in recent years have included promoting immunization in children, reducing healthcare associated infections and providing guidance on emerging infections.

Dr. Brady served as physician-in-chief at Nationwide Children’s from 2005 to 2013 and chair of the Department of Pediatrics at OSU’s College of Medicine from 2006 to 2013. Under his leadership, OSU’s Pediatrics faculty nearly doubled in size. Dr. Brady also oversaw the development of Physician Direct Connect at Nationwide Children’s, a service that puts community pediatricians in nearly immediate contact with specialists for consultations. He is a long-time member of Nationwide Children’s Graduate Medical Education Committee, influencing the training of the next generation of physicians.

At the national level, Dr. Brady has served as chair of the American Academy of Pediatrics’ Committee on Infectious Diseases. He is currently the associate editor of Red Book, the comprehensive infectious disease reference from the AAP. He is also a member of the editorial panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations from the NIH, CDC, HIV Medicine Association, PIDS and AAP. Other activities have involved global immunization advocacy, ongoing education of pediatricians across the country and service on task forces handling issues ranging from circumcision to meningococcal vaccines.

Katherine (Katie) Brind’Amour is a freelance medical and health science writer based in Pennsylvania. She has written about nearly every therapeutic area for patients, doctors and the general public. Dr. Brind’Amour specializes in health literacy and patient education. She completed her BS and MS degrees in Biology at Arizona State University and her PhD in Health Services Management and Policy at The Ohio State University. She is a Certified Health Education Specialist and is interested in health promotion via health programs and the communication of medical information.

Dr. Chisolm is the director of the Center for Innovation in Pediatric Practice at the Abigail Wexner Research Institute at Nationwide Children’s Hospital and is an associate professor of Pediatrics at The Ohio State University College of Medicine and Public Health. She is a health services epidemiologist whose research is focused on measuring and improving the effectiveness, efficiency, and equity of pediatric health care.

Much of her current research is focused on the role of health care technology in improving pediatric health care quality. She is also interested in research investigating the factors associated with use of e-health services by at-risk youth. In addition, Dr. Chisolm serves as a resource to Nationwide Children’s Hospital clinical researchers on issues including: the use of clinical and administrative data in research, cost-effectiveness analysis, and quality indicator development.

Susan Colace, MD, is the Co-Director of the Program for Personalized Medicine and Pharmacogenomics in Pediatric Hematology/Oncology/Blood and Marrow Transplant at Nationwide Children's Hospital and an Assistant Professor at The Ohio State University College of Medicine. Dr. Colace received her medical degree from Wake Forest University School of Medicine and completed her residency at Children's Hospital of Alabama. Dr. Colace completed her fellowship training at Monroe Carrell Jr. Children's Hospital and Vanderbilt University Medical Center.

She is board-certified in general pediatrics, pediatric hematology/oncology and clinical pharmacology. Her research interests include pharmacogenomics, cancer genetics, and chemotherapy toxicities. Clinically, she sees primarily oncology patients with a focus on leukemia and cancer predisposition syndromes.

Dr. Kristin Crichton is a child abuse pediatrician at Nationwide Children's Hospital in Columbus, Ohio. She is board-certified in general pediatrics and child abuse pediatrics. Her clinical interests include child sexual abuse, child physical abuse and caring for children in foster care; her research interests include improving early detection of physical abuse. Dr. Crichton has master’s degrees in both public health and experimental psychology. She serves on the Biomedical Ethics Committee at Nationwide Children's. Additionally, Dr. Crichton is a member of the Ray Helfer Society and an active member of the AAP Ohio Chapter Committee on Child Abuse and Neglect.

Linda Cripe, MD, is a professor of pediatrics and a pediatric cardiologist for The Heart Center. She is also a member of the physician team for the Neuromuscular Disorders section of The Neurosciences Center at Nationwide Children's Hospital. Dr. Cripe completed her residency at the University of Iowa Hospitals and Clinics. She served as a pediatric cardiology fellow at the University of Iowa Hospitals and Clinics, and at Children's Hospital Boston. Before coming to Nationwide Children's, Dr. Cripe spent 12 years at Cincinnati Children's Hospital Medical Center. Dr. Cripe's clinical interests focus on non-invasive cardiac imaging specifically echocardiography as well as on the care and treatment of cardiomyopathy associated with neuromuscular disease, such as Duchenne muscular dystrophy. She was a member of the Centers for Disease Control (CDC) National Steering Committee Duchenne Muscular Dystrophy Standards of Care, and has been an invited lecturer nationally and internationally on cardiomyopathy related to DMD. Dr. Cripe is currently is a member of the Scientific Advisory Board for Parent Project Muscular Dystrophy.

Dr. Cripe is chief of the Division of Hematology, Oncology and Blood and Marrow Transplantation at Nationwide Children’s Hospital. His clinical interests include gene and viral therapies for solid tumors in children, including brain tumors, neuroblastoma and bone and soft tissue sarcomas. Dr. Cripe’s current research focuses on developing and testing new therapies for pediatric solid tumors and translating those findings into clinical studies. He was among the first in the country to launch clinical trials of attenuated oncolytic viruses in children.